[1] Nedkoff L, Briffa T, Zemedikun D, et al.Global trends in atherosclerotic cardiovascular disease[J]. Clin Ther, 2023,45:1087-1091. [2] Eggers KM, Batra G, Lindahl B, et al.Temporal biomarker concentration patterns during the early course of acute coronary syndrome[J]. Clin Chem Lab Med,Published online February 13, 2024. doi:10.1515/cclm-2023-1253. [3] Zhu XY, Yang DD, Zhang KJ,et al. Comparative analysis of four nutritional scores predicting the incidence of MACE in older adults with acute coronary syndromes after PCI[J]. Sci Rep, 2023.doi:10.1038/s41598-023-47793-3. [4] Mok Y, Dardari Z, Sang Y,et al. Universal risk prediction for individuals with and without atherosclerotic cardiovascular disease[J]. J Am Coll Cardiol,2024,83:562-573. [5] McCallum W, Sarnak MJ. Cardiorenal syndrome in the hospital[J]. Clin J Am Soc Nephrol, 2023.doi:10.2215/CJN.0000000000000064. [6] Dutta A, Saha S, Bahl A,et al. A comprehensive review of acute cardio-renal syndrome: need for novel biomarkers[J]. Front Pharmacol, 2023. doi:10.3389/fphar.2023.1152055. [7] Duan S, Li Y, Yang P. Predictive value of blood urea nitrogen in heart failure: a systematic review and Meta-analysis[J]. Front Cardiovasc Med, 2023. doi:10.3389/fcvm.2023.1189884. [8] Zhang K, Yang L, Wu X,et al. Urea nitrogen-to-albumin ratio predicts ventricular aneurysm formation in ST-segment elevation myocardial infarction[J]. ESC Heart Fail.Published online January 17, 2024.doi:10.1002/ehf2.14620. [9] Pan Q, Peng Y, Ni H,et al. Blood-urea-nitrogen-to-serum-albumin ratio in predicting the value of patients with contrast-induced nephropathy for coronary heart disease[J].Published online January 28, 2024. doi:10.1007/s11255-023-03915-4. [10] Ugwuowo U, Yamamoto Y, Arora T,et al.Real-time prediction of acute kidney injury in hospitalized adults: implementation and proof of concept[J].Am J Kidney Dis,2020,76:806-814. [11] Adam AM, Nasir SAR, Merchant AZ, et al.Efficacy of serum blood urea nitrogen, creatinine and electrolytes in the diagnosis and mortality risk assessment of patients with acute coronary syndrome[J]. Indian Heart J, 2018,70:353-359. [12] Shibata K, Wakabayashi K, Ishinaga T, et al.Feasibility, safety, and long-term outcomes of zero-contrast percutaneous coronary intervention in patients with chronic kidney disease[J]. Circ J,2022,86:787-796. [13] Gottlieb ER, Gottlieb SS. A retrospective cohort study of the association of inpatient amlodipine dose with renal complication rates and hospital length of stay[J].Cureus,2023. doi:10.7759/cureus.46237. [14] Satheesh S, Kumar R, Pillai AA, et al.Prognostic values of SYNTAX score Ⅱ in patients with coronary artery disease undergoing percutaneous coronary intervention-cohort study[J]. Indian Heart J, 2024. doi:10.1016/j.ihj.2024.02.005. |